» Articles » PMID: 30532032

Inhibitor Binding Mode and Allosteric Regulation of Na-glucose Symporters

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Dec 12
PMID 30532032
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Sodium-dependent glucose transporters (SGLTs) exploit sodium gradients to transport sugars across the plasma membrane. Due to their role in renal sugar reabsorption, SGLTs are targets for the treatment of type 2 diabetes. Current therapeutics are phlorizin derivatives that contain a sugar moiety bound to an aromatic aglycon tail. Here, we develop structural models of human SGLT1/2 in complex with inhibitors by combining computational and functional studies. Inhibitors bind with the sugar moiety in the sugar pocket and the aglycon tail in the extracellular vestibule. The binding poses corroborate mutagenesis studies and suggest a partial closure of the outer gate upon binding. The models also reveal a putative Na binding site in hSGLT1 whose disruption reduces the transport stoichiometry to the value observed in hSGLT2 and increases inhibition by aglycon tails. Our work demonstrates that subtype selectivity arises from Na-regulated outer gate closure and a variable region in extracellular loop EL5.

Citing Articles

Metabolic Energy is Stored in a Homeostatic Trans-Membrane Water Barochemical Gradient.

Springer Jr C, Pike M, Barbara T J Membr Biol. 2025; .

PMID: 40009106 DOI: 10.1007/s00232-024-00332-1.


Click Reaction Inspired Enzyme Inhibitors in Diabetes Care: An Update in the Field of Chronic Metabolic Disorder.

Mudgal D, Yadav N, Srivastava G, Mishra M, Mishra V Curr Pharm Des. 2024; 31(4):261-291.

PMID: 39410885 DOI: 10.2174/0113816128310031240923062555.


A Futile Cycle?: Tissue Homeostatic Trans-Membrane Water Co-Transport: Kinetics, Thermodynamics, Metabolic Consequences.

Springer Jr C, Pike M, Barbara T bioRxiv. 2024; .

PMID: 38659823 PMC: 11042311. DOI: 10.1101/2024.04.17.589812.


Transport mechanism of presynaptic high-affinity choline uptake by CHT1.

Qiu Y, Gao Y, Huang B, Bai Q, Zhao Y Nat Struct Mol Biol. 2024; 31(4):701-709.

PMID: 38589607 DOI: 10.1038/s41594-024-01259-w.


Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models.

Castoldi G, Carletti R, Barzaghi F, Meani M, Zatti G, Perseghin G Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543148 PMC: 10975335. DOI: 10.3390/ph17030362.


References
1.
Perez C, Koshy C, Yildiz O, Ziegler C . Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP. Nature. 2012; 490(7418):126-30. DOI: 10.1038/nature11403. View

2.
Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View

3.
Wang J, Wang W, Kollman P, Case D . Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006; 25(2):247-60. DOI: 10.1016/j.jmgm.2005.12.005. View

4.
Coady M, Wallendorff B, Lapointe J . Characterization of the transport activity of SGLT2/MAP17, the renal low-affinity Na-glucose cotransporter. Am J Physiol Renal Physiol. 2017; 313(2):F467-F474. DOI: 10.1152/ajprenal.00628.2016. View

5.
Scholl-Burgi S, Santer R, Ehrich J . Long-term outcome of renal glucosuria type 0: the original patient and his natural history. Nephrol Dial Transplant. 2004; 19(9):2394-6. DOI: 10.1093/ndt/gfh366. View